FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy
FDA.gov The U.S. Food and Drug Administration today allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction following mastectomy and in the treatment of underdeveloped breasts and soft tissue deformities. |
December 21, 2016 at 04:35PM | marketing - Google News
FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy - FDA.gov
marketing - Google News
Nenhum comentário:
Postar um comentário